NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy Inc. ("New Fortress" or "the Company") (NASDAQ:NFE). Investors who purchased New Fortress securities prior to December 2, 2022, and continue to hold to the present, are […]

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Premier, Inc. ("Premier" or "the Company") (NASDAQ:PINC). Investors who purchased Premier securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PINC. Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Five9, Inc. ("Five9" or "the Company") (NASDAQ:FIVN). Investors who purchased Five9 securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPLR Infrastructure, LP ("XPLR" or "the Company") (NYSE:NEP). Investors who purchased XPLR securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NEP. Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EngageSmart, Inc. ("EngageSmart" or "the Company") (NYSE:ESMT). Investors who purchased EngageSmart securities prior to October 23, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AstraZeneca and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ:APLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are